Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7293 p404
3 April 2004

This article
Reprint
Photocopy

  Acrobat Reader


News summary


As new financial year starts, NHS structural changes take effect

Changes to the NHS in England, Wales and Scotland come into effect this month. Principal among them are a new contract for the delivery of primary care and a new contract for hospital consultants. Both changes apply throughout the UK.

Inherent in the new GP contract is a one-third increase in primary care spending over four years. GPs will be able to opt out of providing out-of-hours care, which becomes a primary care trust responsibility.

On top of the basic GP contract, GPs and others, including pharmacists, will be able to offer extra primary care services under PCT contracts.

Other changes that are specific to England include the creation of foundation trusts and the Commission for Healthcare Audit and Inspection (CHAI) and the transfer of responsibility for prison health services from the Home Office to PCTs.

Foundation trusts will be independent public benefit corporations free to decide their own clinical priorities. They will not be subject to performance management by strategic health authorities or the Department of Health.

CHAI replaces the Commission for Health Improvement. It is expected to adopt a more vigorous approach to the inspection of NHS services and service providers than its predecessor.

In Scotland, NHS trusts will be abolished and control of hospital services returned to health boards, which now include local authority representatives as part of a move to join up health and social care.

No structural changes are being made to the NHS in Wales this month, but steps to reduce waiting lists are being taken.

Patients who have been on a waiting list for more than 18 months are to be offered the opportunity to be treated at a hospital in England, under the “second offer initiative”.

There will also be a new Health Care Inspectorate Wales, with a remit similar to that of CHAI in England.

Back to Top


©The Pharmaceutical Journal